We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+10.4%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$20.1B
AUM Growth
+$951M
Cap. Flow
-$224M
Cap. Flow %
-1.12%
Top 10 Hldgs %
32.44%
Holding
721
New
63
Increased
299
Reduced
261
Closed
36

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$55.1M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$46.1M
3
BABA icon
Alibaba
BABA
+$45M
4
NEE icon
NextEra Energy
NEE
+$40.9M
5
AMZN icon
Amazon
AMZN
+$38.3M

Top Sells

Rank Stock Value
1
EQIX icon
Equinix
EQIX
+$50.3M
2
META icon
Meta Platforms (Facebook)
META
+$44.2M
3
PG icon
Procter & Gamble
PG
+$34.1M
4
ZTS icon
Zoetis
ZTS
+$33.6M
5
CAH icon
Cardinal Health
CAH
+$32.2M

Sector Composition

Rank Sector Weight
1 Technology 34.01%
2 Healthcare 26.73%
3 Financials 11.13%
4 Consumer Discretionary 7.93%
5 Communication Services 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VERA icon
176
Vera Therapeutics
VERA
$2.41B
$22.8M 0.11%
449,554
+22,365
+5% +$794K
IBM icon
177
IBM
IBM
$215B
$22.8M 0.11%
76,807
+7,452
+11% +$2.23M
NTRA icon
178
Natera
NTRA
$36.5B
$22.7M 0.11%
99,146
-668
-0.7% -$139K
SHOP icon
179
Shopify
SHOP
$172B
$22.4M 0.11%
139,005
+54,723
+65% +$8.79M
CI icon
180
Cigna
CI
$79.5B
$22.1M 0.11%
80,184
+3,021
+4% +$847K
MEDP icon
181
Medpace
MEDP
$16.3B
$21.9M 0.11%
39,035
+21,814
+127% +$12.4M
BBIO icon
182
BridgeBio Pharma
BBIO
$16.4B
$21.3M 0.11%
278,888
+129,902
+87% +$8.53M
KMB icon
183
Kimberly-Clark
KMB
$37.6B
$21.3M 0.11%
211,103
+188,509
+834% +$20.6M
DE icon
184
Deere & Co
DE
$171B
$21.1M 0.11%
45,360
+23,138
+104% +$10.9M
VLTO icon
185
Veralto
VLTO
$23.9B
$21.1M 0.11%
210,965
-31,225
-13% -$3.16M
CAT icon
186
Caterpillar
CAT
$383B
$20.9M 0.1%
36,497
+3,858
+12% +$2.14M
DYN icon
187
Dyne Therapeutics
DYN
$4.27B
$20.7M 0.1%
1,057,263
+223,341
+27% +$4.23M
EW icon
188
Edwards Lifesciences
EW
$48.2B
$20M 0.1%
234,968
+172,978
+279% +$14.2M
NKE icon
189
Nike
NKE
$63.8B
$19.7M 0.1%
308,983
+157,619
+104% +$10.3M
DECK icon
190
Deckers Outdoor
DECK
$14B
$19.5M 0.1%
188,303
+82,220
+78% +$7.71M
SNDX icon
191
Syndax Pharmaceuticals
SNDX
$1.75B
$19.4M 0.1%
925,332
– –
DNLI icon
192
Denali Therapeutics
DNLI
$3.74B
$19.3M 0.1%
1,166,379
+332,797
+40% +$5.62M
SOLS
193
Solstice Advanced Materials
SOLS
$9.12B
– –
0
– –
AMAT icon
194
Applied Materials
AMAT
$376B
$18.9M 0.09%
73,666
-105,801
-59% -$25.4M
PODD icon
195
Insulet
PODD
$11.7B
$18.9M 0.09%
66,502
+30,225
+83% +$9.45M
PYPL icon
196
PayPal
PYPL
$51.8B
$18.9M 0.09%
323,447
-299,612
-48% -$19.5M
RCUS icon
197
Arcus Biosciences
RCUS
$3.39B
$18.8M 0.09%
790,613
+412,172
+109% +$8.41M
XENE icon
198
Xenon Pharmaceuticals
XENE
$6.3B
$18.7M 0.09%
417,402
+20,766
+5% +$872K
RARE icon
199
Ultragenyx Pharmaceutical
RARE
$2.53B
$18.4M 0.09%
799,384
+44,670
+6% +$1.47M
TVTX icon
200
Travere Therapeutics
TVTX
$5.16B
$17.9M 0.09%
468,556
-44,125
-9% -$1.43M
6 7
8
9 10

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2025 Portfolio in Review

As of Q4 2025, Candriam SCA held 721 positions worth $20.1B, up 5% from $19.1B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Candriam SCA's Q4 2025 filing shows 63 new, 299 increased, 261 reduced and 36 closed positions. Its largest new stake was Alibaba: 276,080 shares worth $40.5M. The largest sale was Equinix, an estimated $50.3M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

  • Candriam SCA's largest Q4 2025 buy was Alibaba: 276,080 shares worth $40.5M.
  • Candriam SCA added most to AbbVie in Q4 2025, an estimated $55.1M increase.
  • Candriam SCA's biggest Q4 2025 reduction was Equinix, cutting an estimated $50.3M.
  • Candriam SCA fully exited Universal Display in Q4 2025, selling an estimated $27.1M.
  • Candriam SCA's ten largest holdings make up 32% of its $20.1B portfolio in Q4 2025.
  • Candriam SCA opened 63 new positions and closed 36 in Q4 2025.
  • Candriam SCA's portfolio value rose 5% quarter-over-quarter to $20.1B.

Based on Candriam SCA's 13F filing for Q4 2025, filed 13 Feb 2026.